Current status of the P2P CPP project
The P2P CPP team aims to develop a safe and efficient means of getting drugs into cells. This aim is relevant for a broad range of potential drugs with intracellular targets. Here, head of the project Hanne Poulsen, provides a status update on the P2P CPP project.
![](/fileadmin/_processed_/4/5/csm_Hanne_progress_60d5bfbe49.jpg)
Cell penetrating peptides (CPPs) used therapeutically for drugs that cannot enter the cells without help. The aim of the P2P CPP project is to gain a general understanding of the CPPs - together with Stipe Therapeutics, who are industry partners in the project.
”We’d like to know more about the side effects, that CPPs can cause - and why these effects arise.” says Hanne Poulsen, head of the P2P CPP project, and continues:
”These are intriguing, basic science questions, but answering them would also be of great practical use for industries aiming for intracellular targets”.